Education
About Us
Working with TipRanks
Follow Us
Amgen Inc (AMGN)
:AMGN
AMGN Analyst Ratings
Moderate Buy
10 Buy
6 Hold
1 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
AMGN Stock 12 Month Forecast
Average Price Target
$329.92
▲(7.92% Upside)
| Highest Price Target$389.00 | Average Price Target$329.92 | Lowest Price Target$280.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Piper Sandler
Reiterated
03/25/25
TD Cowen
Reiterated
03/10/25
Morgan Stanley
Reiterated
03/10/25
Jefferies
Reiterated
03/10/25
William Blair
Reiterated
03/10/25
Leerink Partners
Reiterated
03/09/25
Wells Fargo
Reiterated
03/09/25
Bank of America Securities
Reiterated
03/05/25
Bernstein
Reiterated
02/20/25
Citi
Reiterated
02/13/25
Erste Group
―
Buy
―
Upgraded
02/05/25
Amgen upgraded to Buy from Hold at Erste GroupAmgen upgraded to Buy from Hold at Erste Group
Cantor Fitzgerald
$405→$340
Buy
11.22%
Upside
Reiterated
02/05/25
Amgen (AMGN) PT Lowered to $340 at Cantor FitzgeraldShe said, "AMG 513 clinical hold raises some eyes (we still dont know the MOA): And its taking away attention from a good quarter from the AMGN team.
Truist Financial
$298
Hold
-2.52%
Downside
Reiterated
02/05/25
Amgen (AMGN) Receives a Hold from Truist Financial
RBC Capital
$324→$320
Buy
4.67%
Upside
Reiterated
02/04/25
Amgen (AMGN) Gets a Buy from RBC Capital
Mizuho Securities
―
Hold
―
Reiterated
02/04/25
Cautious Outlook on Amgen Amid Clinical Holds and Future ProspectsWe believe that many questions remain unanswered on MariTide (AMG 133). Valuation still the key issue with the stock, in our view; while our DCF is ~$200 (inclusive of some obesity), to explain the current trading levels, investors appear to be relying on P/E based valuation methodologies.
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Piper Sandler
Reiterated
03/25/25
TD Cowen
Reiterated
03/10/25
Morgan Stanley
Reiterated
03/10/25
Jefferies
Reiterated
03/10/25
William Blair
Reiterated
03/10/25
Leerink Partners
Reiterated
03/09/25
Wells Fargo
Reiterated
03/09/25
Bank of America Securities
Reiterated
03/05/25
Bernstein
Reiterated
02/20/25
Citi
Reiterated
02/13/25
Erste Group
―
Buy
―
Upgraded
02/05/25
Amgen upgraded to Buy from Hold at Erste GroupAmgen upgraded to Buy from Hold at Erste Group
Cantor Fitzgerald
$405→$340
Buy
11.22%
Upside
Reiterated
02/05/25
Amgen (AMGN) PT Lowered to $340 at Cantor FitzgeraldShe said, "AMG 513 clinical hold raises some eyes (we still dont know the MOA): And its taking away attention from a good quarter from the AMGN team.
Truist Financial
$298
Hold
-2.52%
Downside
Reiterated
02/05/25
Amgen (AMGN) Receives a Hold from Truist Financial
RBC Capital
$324→$320
Buy
4.67%
Upside
Reiterated
02/04/25
Amgen (AMGN) Gets a Buy from RBC Capital
Mizuho Securities
―
Hold
―
Reiterated
02/04/25
Cautious Outlook on Amgen Amid Clinical Holds and Future ProspectsWe believe that many questions remain unanswered on MariTide (AMG 133). Valuation still the key issue with the stock, in our view; while our DCF is ~$200 (inclusive of some obesity), to explain the current trading levels, investors appear to be relying on P/E based valuation methodologies.
AMGN Analyst Recommendation Trends
Rating
Nov 24
Dec 24
Jan 25
Feb 25
Mar 25
Strong Buy
0
0
0
0
0
Buy
43
38
31
24
27
Hold
34
26
18
11
13
Sell
1
1
2
3
3
Strong Sell
0
0
0
0
0
total
78
65
51
38
43
Each month's total comprises the sum of three months' worth of ratings.
AMGN Financial Forecast
AMGN Stock Forecast FAQ
What is AMGN’s average 12-month price target, according to analysts?
Based on analyst ratings, Amgen Inc’s 12-month average price target is $329.92.
What is AMGN’s upside potential, based on the analysts’ average price target?
Amgen Inc has 7.92% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is AMGN a Buy, Sell or Hold?
Amgen Inc has a consensus rating of Moderate Buy which is based on 10 buy ratings, 6 hold ratings and 1 sell ratings.
What is Amgen Inc’s price target?
The average price target for Amgen Inc is $329.92. This is based on 17 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $389.00 ,the lowest forecast is $280.00. The average price target represents 7.92% Increase from the current price of $305.71.
The highest analyst price target is $389.00 ,the lowest forecast is $280.00. The average price target represents 7.92% Increase from the current price of $305.71.
What do analysts say about Amgen Inc?
Amgen Inc’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 17 Wall Streets Analysts.
How can I buy shares of AMGN?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.